NOVARTIS
Live / Applied — Third extension granted (statement of use) (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 11 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98308022
- Mark type
- Design + words
- Filed
- 11 Dec 2023
- Published for opposition
- 14 May 2024
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields
- Class 010 — Medical apparatus: Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention and treatment of haematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of urinary diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of ophthalmological diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for introducing pharmaceutical preparations into the human body
- Class 041 — Education and entertainment services: Providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 3 GRANTED
- 05 Jan 2026 — SOU EXTENSION 3 FILED
- 06 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2025 — CORRECTED NOA E-MAILED
- 31 Dec 2025 — SOU EXTENSION 2 GRANTED
- 30 Jun 2025 — SOU EXTENSION 2 FILED
- 31 Dec 2025 — DIVISIONAL PROCESSING COMPLETE
- 01 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 01 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2025 — SOU EXTENSION 1 GRANTED